Activation and evasion of innate antiviral immunity by herpes simplex virus

Viruses

Volumn 1, Issue 3, 2009, Pages 737-759

  Melchjorsen, Jesper ^a   Matikainen, Sampsa ^b   Paludan, Søren R ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Evasion; Herpes simplex virus; Innate; Interferon; Viral immunity

Indexed keywords

EID: 77954895668     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v1030737     Document Type: Review

References (137)

1. Roizman, B.; Knipe, D.M.; Whitley, R.J. Herpes simplex virus, in Fields Virology, 5 ed.; Knipe, D.M.; Howley, P.M.; Griffin, D.E.; Lamb, R.A.; Martin, M.A.; Roizman, B.; Straus, S.E., editors; Lippincott Williams & Wilkins: 2007; Vol. 2, Chapter 67, pp. 2501-2601.
2. Pinto, A.J.; Morahan, P.S.; Brinton, M.; Stewart, D.; Gavin, E. Comparative therapeutic efficacy of recombinant interferons-alpha,-beta, and-gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J. Interferon Res. 1990, 10, 293-298.
3. Leib, D.A.; Harrison, T.E.; Laslo, K.M.; Machalek, M.A.; Moorman, N.J.; Virgin, H.W. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 1999, 189, 663-672.
4. Dupuis, S.; Jouanguy, E.; Al Hajjar, S.; Fieschi, C.; Al Mohsen, I.Z.; Al Jumaah, S.; Yang, K.; Chapgier, A.; Eidenschenk, C.; Eid, P.; Al Ghonaium, A.; Tufenkeji, H.; Frayha, H.; Al Gazlan, S.; Al Rayes, H.; Schreiber, R.D.; Gresser, I.; Casanova, J.L. Impaired response to interferonalpha/ beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 2003, 33, 388-391.
5. Ank, N.; Iversen, M.B.; Bartholdy, C.; Staeheli, P.; Hartmann, R.; Jensen, U.B.; Dagnaes-Hansen, F.; Thomsen, A.R.; Chen, Z.; Haugen, H.; Klucher, K.; Paludan, S.R. An important role for type III Interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J. Immunol. 2008, 180, 2474-2485.
6. Takeuchi, O.; Akira, S. Innate immunity to virus infection. Immunol. Rev. 2009, 227, 75-86.
7. Takaoka, A.; Wang, Z.; Choi, M.K.; Yanai, H.; Negishi, H.; Ban, T.; Lu, Y.; Miyagishi, M.; Kodama, T.; Honda, K.; Ohba, Y.; Taniguchi, T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448, 501-505.
8. Ablasser, A.; Bauernfeind, F.; Hartmann, G.; Latz, E.; Fitzgerald, K.A.; Hornung, V. RIG-Idependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 2009, 10, 1065-1072.
9. Chiu, Y.H.; Macmillan, J.B.; Chen, Z.J. RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway. Cell 2009, 138, 576-591.
10. Kurt-Jones, E.A.; Chan, M.; Zhou, S.; Wang, J.; Reed, G.; Bronson, R.; Arnold, M.M.; Knipe, D.M.; Finberg, R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 2004, 101, 1315-1320.
11. Aravalli, R.N.; Hu, S.; Rowen, T.N.; Palmquist, J.M.; Lokensgard, J.R. Cutting Edge: TLR2-Mediated Proinflammatory Cytokine and Chemokine Production by Microglial Cells in Response to Herpes Simplex Virus. J. Immunol. 2005, 175, 4189-4193.
12. Reske, A.; Pollara, G.; Krummenacher, C.; Katz, D.R.; Chain, B.M. Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J. Immunol. 2008, 180, 7525-7536.
13. Lund, J.; Sato, A.; Akira, S.; Medzhitov, R.; Iwasaki, A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 2003, 198, 513-520.
14. Hochrein, H.; Schlatter, B.; O'Keeffe, M.; Wagner, C.; Schmitz, F.; Schiemann, M.; Bauer, S.; Suter, M.; Wagner, H. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and-independent pathways. Proc. Natl. Acad. Sci. USA 2004, 101, 11416-11421.
15. Malmgaard, L.; Melchjorsen, J.; Bowie, A.G.; Mogensen, S.C.; Paludan, S.R. Viral activation of macrophages through TLR-dependent and-independent pathways. J. Immunol. 2004, 173, 6890-6898.
16. Rasmussen, S.B.; Sorensen, L.N.; Malmgaard, L.; Ank, N.; Baines, J.D.; Chen, Z.J.; Paludan, S.R. Type I IFN production during herpes simplex virus infection is controlled by cell-type specific viral recognition through TLR9, the MAVS pathway, and novel recognition systems. J. Virol. 2007, 81, 13315-13324.
17. Zhang, S.Y.; Jouanguy, E.; Ugolini, S.; Smahi, A.; Elain, G.; Romero, P.; Segal, D.; Sancho-Shimizu, V.; Lorenzo, L.; Puel, A.; Picard, C.; Chapgier, A.; Plancoulaine, S.; Titeux, M.; Cognet, C.; von Bernuth, H.; Ku, C.L.; Casrouge, A.; Zhang, X.X.; Barreiro, L.; Leonard, J.; Hamilton, C.; Lebon, P.; Heron, B.; Vallee, L.; Quintana-Murci, L.; Hovnanian, A.; Rozenberg, F.; Vivier, E.; Geissmann, F.; Tardieu, M.; Abel, L.; Casanova, J.L. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317, 1522-1527.
18. Dolan, A.; Jamieson, F.E.; Cunningham, C.; Barnett, B.C.; McGeoch, D.J. The genome sequence of herpes simplex virus type 2. J. Virol. 1998, 72, 2010-2021.
19. Fruh, K.; Gruhler, A.; Krishna, R.M.; Schoenhals, G.J. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway. Immunol. Rev. 1999, 168, 157-166.
20. Homa, F.L.; Brown, J.C. Capsid assembly and DNA packaging in herpes simplex virus. Rev. Med. Virol. 1997, 7, 107-122.
21. Ellermann-Eriksen, S. Autocrine secretion of interferon-alpha/beta and tumour necrosis factoralpha synergistically activates mouse macrophages after infection with herpes simplex virus type 2. J. Gen. Virol. 1993, 74, 2191-2199.
22. Mittnacht, S.; Straub, P.; Kirchner, H.; Jacobsen, H. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 1988, 164, 201-210.
23. Oberman, F.; Panet, A. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J. Gen. Virol. 1988, 69, 1167-1177.
24. Sainz, B., Jr.; Halford, W.P. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 2002, 76, 11541-11550.
25. Vollstedt, S.; Arnold, S.; Schwerdel, C.; Franchini, M.; Alber, G.; Di Santo, J.P.; Ackermann, M.; Suter, M. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 2004, 78, 3846-3850.
26. Gresser, I.; Tovey, M.G.; Maury, C.; Bandu, M.T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J. Exp. Med. 1976, 144, 1316-1323.
27. Melchjorsen, J.; Siren, J.; Julkunen, I.; Paludan, S.R.; Matikainen, S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J. Gen. Virol. 2006, 87, 1099-1108.
28. Der, S.D.; Zhou, A.; Williams, B.R.; Silverman, R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 1998, 95, 15623-15628.
29. Khabar, K.S.; Dhalla, M.; Siddiqui, Y.; Zhou, A.; Al Ahdal, M.N.; Der, S.D.; Silverman, R.H.; Williams, B.R. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 2000, 20, 653-659.
30. Melchjorsen, J.; Pedersen, F.S.; Mogensen, S.C.; Paludan, S.R. Herpes simplex virus selectively induces expression of the CC Chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0. J. Virol. 2002, 76, 2780-2788.
31. Zheng, X.; Silverman, R.H.; Zhou, A.; Goto, T.; Kwon, B.S.; Kaufman, H.E.; Hill, J.M. Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest Ophthalmol. Vis. Sci. 2001, 42, 120-126.
32. Carr, D.J.; Al khatib, K.; James, C.M.; Silverman, R. Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J. Neuroimmunol. 2003, 141, 40-46.
33. Fujihara, M.; Milligan, J.R.; Kaji, A. Effect of 2',5'-oligoadenylate on herpes simplex virusinfected cells and preventive action of 2',5'-oligoadenylate on the lethal effect of HSV-2. J. Interferon Res. 1989, 9, 691-707.
34. Neville, L.F.; Mathiak, G.; Bagasra, O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev. 1997, 8, 207-219.
35. Levy, D.E.; Marie, I.; Smith, E.; Prakash, A. Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J. Interferon Cytokine Res. 2002, 22, 87-93.
36. Miettinen, M.; Sareneva, T.; Julkunen, I.; Matikainen, S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2001, 2, 349-355.
37. Siren, J.; Pirhonen, J.; Julkunen, I.; Matikainen, S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J. Immunol. 2005, 174, 1932-1937.
38. Foy, E.; Li, K.; Sumpter, R., Jr.; Loo, Y.M.; Johnson, C.L.; Wang, C.; Fish, P.M.; Yoneyama, M.; Fujita, T.; Lemon, S.M.; Gale, M., Jr. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 2005, 102, 2986-2991.
39. Kang, D.C.; Gopalkrishnan, R.V.; Wu, Q.; Jankowsky, E.; Pyle, A.M.; Fisher, P.B. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 2002, 99, 637-642.
40. Ank, N.; West, H.; Bartholdy, C.; Eriksson, K.; Thomsen, A.R.; Paludan, S.R. Lambda Interferon (IFN-{lambda}), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In vivo. J. Virol. 2006, 80, 4501-4509.
41. Kotenko, S.V.; Gallagher, G.; Baurin, V.V.; Lewis-Antes, A.; Shen, M.; Shah, N.K.; Langer, J.A.; Sheikh, F.; Dickensheets, H.; Donnelly, R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4, 69-77.
42. Sheppard, P.; Kindsvogel, W.; Xu, W.; Henderson, K.; Schlutsmeyer, S.; Whitmore, T.E.; Kuestner, R.; Garrigues, U.; Birks, C.; Roraback, J.; Ostrander, C.; Dong, D.; Shin, J.; Presnell, S.; Fox, B.; Haldeman, B.; Cooper, E.; Taft, D.; Gilbert, T.; Grant, F.J.; Tackett, M.; Krivan, W.; McKnight, G.; Clegg, C.; Foster, D.; Klucher, K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003, 4, 63-68.
43. Coccia, E.M.; Severa, M.; Giacomini, E.; Monneron, D.; Remoli, M.E.; Julkunen, I.; Cella, M.; Lande, R.; Uze, G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 2004, 34, 796-805.
44. Karupiah, G.; Xie, Q.W.; Buller, R.M.; Nathan, C.; Duarte, C.; MacMicking, J.D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993, 261, 1445-1448.
45. Chesler, D.A.; Reiss, C.S. The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 2002, 13, 441-454.
46. Vollstedt, S.; Franchini, M.; Alber, G.; Ackermann, M.; Suter, M. Interleukin-12-and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1. J. Virol. 2001, 75, 9596-9600.
47. Sen, G.C. Viruses and interferons. Annu. Rev. Microbiol. 2001, 55, 255-281.
48. Malmgaard, L.; Paludan, S.R. Interferon (IFN)-alpha/beta, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-gamma during infection with herpes simplex virus type 2. J. Gen. Virol. 2003, 84, 2497-2500.
49. Munder, M.; Mallo, M.; Eichmann, K.; Modolell, M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J. Exp. Med. 1998, 187, 2103-2108.
50. Schindler, H.; Lutz, M.B.; Rollinghoff, M.; Bogdan, C. The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J. Immunol. 2001, 166, 3075-3082.
51. Stober, D.; Schirmbeck, R.; Reimann, J. IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. J. Immunol. 2001, 167, 957-965.
52. Kodukula, P.; Liu, T.; Rooijen, N.V.; Jager, M.J.; Hendricks, R.L. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 1999, 162, 2895-2905.
53. Paludan, S.R.; Mogensen, S.C. Virus-cell interactions regulating induction of tumor necrosis factor alpha production in macrophages infected with herpes simplex virus. J. Virol. 2001, 75, 10170-10178.
54. Malmgaard, L.; Paludan, S.R.; Mogensen, S.C.; Ellermann-Eriksen, S. Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB. J. Gen. Virol. 2000, 81, 3011-3020.
55. Imaizumi, T.; Hatakeyama, M.; Yamashita, K.; Yoshida, H.; Ishikawa, A.; Taima, K.; Satoh, K.; Mori, F.; Wakabayashi, K. Interferon-gamma induces retinoic acid-inducible gene-I in endothelial cells. Endothelium 2004, 11, 169-173.
56. Seth, R.B.; Sun, L.; Chen, Z.J. Antiviral innate immunity pathways. Cell Res. 2006, 16, 141-147.
57. Rasmussen, S.B.; Jensen, S.B.; Nielsen, C.; Quartin, E.; Kato, H.; Chen, Z.J.; Silverman, R.H.; Akira, S.; Paludan, S.R. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 2009, 90, 74-78.
58. Patel, A.; Hanson, J.; McLean, T.I.; Olgiate, J.; Hilton, M.; Miller, W.E.; Bachenheimer, S.L. Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication. Virology 1998, 247, 212-222.
59. Leonard, W.J.; O'Shea, J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 1998, 16, 293-322.
60. Pasieka, T.J.; Lu, B.; Leib, D.A. Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1. J. Virol. 2008, 82, 6052-6055.
61. Chou, J.; Chen, J.J.; Gross, M.; Roizman, B. Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5-mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 1995, 92, 10516-10520.
62. He, B.; Gross, M.; Roizman, B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 1997, 94, 843-848.
63. Poppers, J.; Mulvey, M.; Khoo, D.; Mohr, I. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J. Virol. 2000, 74, 11215-11221.
64. Peters, G.A.; Khoo, D.; Mohr, I.; Sen, G.C. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J. Virol. 2002, 76, 11054-11064.
65. Mulvey, M.; Camarena, V.; Mohr, I. Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and gamma(1)34.5 gene products. J. Virol. 2004, 78, 10193-10196.
66. Orvedahl, A.; Alexander, D.; Talloczy, Z.; Sun, Q.; Wei, Y.; Zhang, W.; Burns, D.; Leib, D.A.; Levine, B. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host. Microbe 2007, 1, 23-35.
67. Sanchez, R.; Mohr, I. Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein. J. Virol. 2007, 81, 3455-3464.
68. Sobol, P.T.; Mossman, K.L. ICP0 Prevents RNase L-Independent rRNA Cleavage in Herpes Simplex Virus Type 1-Infected Cells. J. Virol. 2006, 80, 218-225.
69. Cayley, P.J.; Davies, J.A.; McCullagh, K.G.; Kerr, I.M. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. Eur.J. Biochem. 1984, 143, 165-174.
70. Mossman, K.L.; Saffran, H.A.; Smiley, J.R. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 2000, 74, 2052-2056.
71. Harle, P.; Sainz, B., Jr.; Carr, D.J.; Halford, W.P. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology 2002, 293, 295-304.
72. Lin, R.; Noyce, R.S.; Collins, S.E.; Everett, R.D.; Mossman, K.L. The herpes simplex virus ICP0 RING finger domain inhibits IRF3 and IRF7-mediated activation of interferon-stimulated genes. J. Virol. 2004, 78, 1675-1684.
73. Melroe, G.T.; DeLuca, N.A.; Knipe, D.M. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 2004, 78, 8411-8420.
74. Eidson, K.M.; Hobbs, W.E.; Manning, B.J.; Carlson, P.; DeLuca, N.A. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral Infection. J. Virol. 2002, 76, 2180-2191.
75. Halford, W.P.; Weisend, C.; Grace, J.; Soboleski, M.; Carr, D.J.; Balliet, J.W.; Imai, Y.; Margolis, T.P.; Gebhardt, B.M. ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virol. J. 2006, 3, 44.
76. Everett, R.D.; Orr, A. Herpes simplex virus type 1 regulatory protein ICP0 aids infection in cells with a preinduced interferon response but does not impede interferon-induced gene induction. J. Virol. 2009, 83, 4978-4983.
77. Everett, R.D.; Young, D.F.; Randall, R.E.; Orr, A. STAT-1-and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J. Virol. 2008, 82, 8871-8881.
78. Johnson, K.E.; Song, B.; Knipe, D.M. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 2008, 374, 487-494.
79. Peri, P.; Mattila, R.K.; Kantola, H.; Broberg, E.; Karttunen, H.S.; Waris, M.; Vuorinen, T.; Hukkanen, V. Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells. Virol. J. 2008, 5, 140.
80. Murphy, J.A.; Duerst, R.J.; Smith, T.J.; Morrison, L.A. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J. Virol. 2003, 77, 9337-9345.
81. Duerst, R.J.; Morrison, L.A. Herpes simplex virus 2 virion host shutoff protein interferes with type I interferon production and responsiveness. Virology 2004, 322, 158-167.
82. Yokota, S.; Yokosawa, N.; Okabayashi, T.; Suzutani, T.; Miura, S.; Jimbow, K.; Fujii, N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 2004, 78, 6282-6286.
83. Yokota, S.; Yokosawa, N.; Kubota, T.; Suzutani, T.; Yoshida, I.; Miura, S.; Jimbow, K.; Fujii, N. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology 2001, 286, 119-124.
84. Suzutani, T.; Nagamine, M.; Shibaki, T.; Ogasawara, M.; Yoshida, I.; Daikoku, T.; Nishiyama, Y.; Azuma, M. The role of the UL41 gene of herpes simplex virus type 1 in evasion of nonspecific host defence mechanisms during primary infection. J. Gen. Virol. 2000, 81, 1763-1771.
85. Verpooten, D.; Ma, Y.; Hou, S.; Yan, Z.; He, B. Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J. Biol. Chem. 2009, 284, 1097-1105.
86. Cheng, G.; Feng, Z.; He, B. Herpes simplex virus 1 infection activates the endoplasmic reticulum resident kinase PERK and mediates eIF-2alpha dephosphorylation by the gamma(1)34.5 protein. J. Virol. 2005, 79, 1379-1388.
87. Daubeuf, S.; Singh, D.; Tan, Y.; Liu, H.; Federoff, H.J.; Bowers, W.J.; Tolba, K. HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 2009, 113, 3264-3275.
88. Hardy, W.R.; Sandri-Goldin, R.M. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J. Virol. 1994, 68, 7790-7799.
89. Sciabica, K.S.; Dai, Q.J.; Sandri-Goldin, R.M. ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J. 2003, 22, 1608-1619.
90. Bryant, H.E.; Wadd, S.E.; Lamond, A.I.; Silverstein, S.J.; Clements, J.B. Herpes simplex virus IE63 (ICP27) protein interacts with spliceosome-associated protein 145 and inhibits splicing prior to the first catalytic step. J. Virol. 2001, 75, 4376-4385.
91. Mogensen, T.H.; Melchjorsen, J.; Malmgaard, L.; Casola, A.; Paludan, S.R. Suppression of proinflammatory cytokine expression by herpes simplex virus type 1. J. Virol. 2004, 78, 5883-5890.
92. Strand, S.S.; Leib, D.A. Role of the VP16-binding domain of vhs in viral growth, host shutoff activity, and pathogenesis. J. Virol. 2004, 78, 13562-13572.
93. Hobbs, W.E.; DeLuca, N.A. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J. Virol. 1999, 73, 8245-8255.
94. Scott, E.S.; Malcomber, S.; O'Hare, P. Nuclear translocation and activation of the transcription factor NFAT is blocked by herpes simplex virus infection. J. Virol. 2001, 75, 9955-9965.
95. Leopardi, R.; Roizman, B. The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc. Natl. Acad. Sci. USA 1996, 93, 9583-9587.
96. Jerome, K.R.; Chen, Z.; Lang, R.; Torres, M.R.; Hofmeister, J.; Smith, S.; Fox, R.; Froelich, C.J.; Corey, L. HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas. J. Immunol. 2001, 167, 3928-3935.
97. Aubert, M.; Blaho, J.A. The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J. Virol. 1999, 73, 2803-2813.
98. Sieg, S.; Yildirim, Z.; Smith, D.; Kayagaki, N.; Yagita, H.; Huang, Y.; Kaplan, D. Herpes simplex virus type 2 inhibition of Fas ligand expression. J. Virol. 1996, 70, 8747-8751.
99. Sieg, S.; Huang, Y.; Kaplan, D. Viral regulation of CD95 expression and apoptosis in T lymphocytes. J. Immunol. 1997, 159, 1192-1199.
100. Fakioglu, E.; Wilson, S.S.; Mesquita, P.M.; Hazrati, E.; Cheshenko, N.; Blaho, J.A.; Herold, B.C. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism. J. Virol. 2008, 82, 9337-9344.
101. Friedman, H.M.; Cohen, G.H.; Eisenberg, R.J.; Seidel, C.A.; Cines, D.B. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 1984, 309, 633-635.
102. Lubinski, J.; Wang, L.; Mastellos, D.; Sahu, A.; Lambris, J.D.; Friedman, H.M. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J. Exp. Med. 1999, 190, 1637-1646.
103. Lubinski, J.; Nagashunmugam, T.; Friedman, H.M. Viral interference with antibody and complement. Semin. Cell Dev. Biol. 1998, 9, 329-337.
104. Salio, M.; Cella, M.; Suter, M.; Lanzavecchia, A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 1999, 29, 3245-3253.
105. Samady, L.; Costigliola, E.; MacCormac, L.; McGrath, Y.; Cleverley, S.; Lilley, C.E.; Smith, J.; Latchman, D.S.; Chain, B.; Coffin, R.S. Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs-HSV vectors for dendritic cell-mediated immunotherapy. J. Virol. 2003, 77, 3768-3776.
106. Fruh, K.; Ahn, K.; Djaballah, H.; Sempe, P.; van Endert, P.M.; Tampe, R.; Peterson, P.A.; Yang, Y. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375, 415-418.
107. Hill, A.; Jugovic, P.; York, I.; Russ, G.; Bennink, J.; Yewdell, J.; Ploegh, H.; Johnson, D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375, 411-415.
108. Ahn, K.; Meyer, T.H.; Uebel, S.; Sempe, P.; Djaballah, H.; Yang, Y.; Peterson, P.A.; Fruh, K.; Tampe, R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 1996, 15, 3247-3255.
109. Hill, A.B.; Barnett, B.C.; McMichael, A.J.; McGeoch, D.J. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol. 1994, 152, 2736-2741.
110. Tigges, M.A.; Leng, S.; Johnson, D.C.; Burke, R.L. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J. Immunol. 1996, 156, 3901-3910.
111. Trgovcich, J.; Johnson, D.; Roizman, B. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1. J. Virol. 2002, 76, 6974-6986.
112. Neumann, J.; Eis-Hubinger, A.M.; Koch, N. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol. 2003, 171, 3075-3083.
113. Stingley, S.W.; Ramirez, J.J.; Aguilar, S.A.; Simmen, K.; Sandri-Goldin, R.M.; Ghazal, P.; Wagner, E.K. Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J. Virol. 2000, 74, 9916-9927.
114. Kim, J.C.; Lee, S.Y.; Kim, S.Y.; Kim, J.K.; Kim, H.J.; Lee, H.M.; Choi, M.S.; Min, J.S.; Kim, M.J.; Choi, H.S.; Ahn, J.K. HSV-1 ICP27 suppresses NF-kappaB activity by stabilizing IkappaBalpha. FEBS Lett. 2008, 582, 2371-2376.
115. Hargett, D.; McLean, T.; Bachenheimer, S.L. Herpes Simplex Virus ICP27 Activation of Stress Kinases JNK and p38. J. Virol. 2005, 79, 8348-8360.
116. Gillis, P.A.; Okagaki, L.H.; Rice, S.A. Herpes simplex virus type 1 ICP27 induces p38 mitogenactivated protein kinase signaling and apoptosis in HeLa cells. J. Virol. 2009, 83, 1767-1777.
117. Hargett, D.; Rice, S.; Bachenheimer, S.L. Herpes simplex virus type 1 ICP27-dependent activation of NF-kappaB. J. Virol. 2006, 80, 10565-10578.
118. Smiley, J.R. Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase? J. Virol. 2004, 78, 1063-1068.
119. Honda, K.; Yanai, H.; Negishi, H.; Asagiri, M.; Sato, M.; Mizutani, T.; Shimada, N.; Ohba, Y.; Takaoka, A.; Yoshida, N.; Taniguchi, T. IRF-7 is the master regulator of type-I interferondependent immune responses. Nature 2005, 434, 772-777.
120. Frey, K.G.; Ahmed, C.M.; Dabelic, R.; Jager, L.D.; Noon-Song, E.N.; Haider, S.M.; Johnson, H.M.; Bigley, N.J. HSV-1-Induced SOCS-1 Expression in Keratinocytes: Use of a SOCS-1 Antagonist to Block a Novel Mechanism of Viral Immune Evasion. J. Immunol. 2009.
121. Mossman, K.L.; Macgregor, P.F.; Rozmus, J.J.; Goryachev, A.B.; Edwards, A.M.; Smiley, J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol. 2001, 75, 750-758.
122. Spencer, C.A.; Dahmus, M.E.; Rice, S.A. Repression of host RNA polymerase II transcription by herpes simplex virus type 1. J. Virol. 1997, 71, 2031-2040.
123. Collins, S.E.; Noyce, R.S.; Mossman, K.L. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J. Virol. 2004, 78, 1706-1717.
124. Hardwicke, M.A.; Sandri-Goldin, R.M. The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection. J. Virol. 1994, 68, 4797-4810.
125. McCarthy, A.M.; McMahan, L.; Schaffer, P.A. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 1989, 63, 18-27.
126. Song, B.; Yeh, K.C.; Liu, J.; Knipe, D.M. Herpes simplex virus gene products required for viral inhibition of expression of G1-phase functions. Virology 2001, 290, 320-328.
127. Zhou, C.; Knipe, D.M. Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme. J. Virol. 2002, 76, 5893-5904.
128. Kawaguchi, Y.; Bruni, R.; Roizman, B. Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J. Virol. 1997, 71, 1019-1024.
129. Sin, J.I.; Kim, J.J.; Pachuk, C.; Satishchandran, C.; Weiner, D.B. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 In vivo. J. Virol. 2000, 74, 11173-11180.
130. Walker, J.; Leib, D.A. Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function. Vaccine 1998, 16, 1-5.
131. Geiss, B.J.; Smith, T.J.; Leib, D.A.; Morrison, L.A. Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain. J. Virol. 2000, 74, 11137-11144.
132. Prechtel, A.T.; Turza, N.M.; Kobelt, D.J.; Eisemann, J.I.; Coffin, R.S.; McGrath, Y.; Hacker, C.; Ju, X.; Zenke, M.; Steinkasserer, A. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J. Gen. Virol. 2005, 86, 1645-1657.
133. Lee, H.K.; Iwasaki, A. Autophagy and antiviral immunity. Curr. Opin. Immunol. 2008, 20, 23-29.
134. Espert, L.; Codogno, P.; Biard-Piechaczyk, M. Involvement of autophagy in viral infections: antiviral function and subversion by viruses. J. Mol. Med. 2007, 85, 811-823.
135. Levine, B.; Deretic, V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 2007, 7, 767-777.
136. Talloczy, Z.; Virgin, H.W.; Levine, B. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy. 2006, 2, 24-29.
137. Alexander, D.E.; Leib, D.A. Xenophagy in herpes simplex virus replication and pathogenesis. Autophagy 2008, 4, 101-103.